ALTU-135 Completed Phase 3 Trials for Exocrine Pancreatic Insufficiency / Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00449878Liprotamase Efficacy Trial in Patients With Cystic Fibrosis-Related Exocrine Pancreatic Insufficiency
NCT00449904Open-Label Phase III Long-Term Safety Trial of Liprotamase